Participated · Series B · Aug 2022

Arine operates an AI-driven medication optimization platform that delivers scalable, personalized medication therapy recommendations to health plans and risk-bearing providers. The platform leverages large, diverse datasets to identify the right individuals, recommend effective interventions, and continuously measure impact. Arine reports outcomes including >10% total cost savings and >40% reduction in hospitalizations, and it experienced >100% growth last year with average contract expansion of 80% with existing clients. The company focuses on improving medication safety, adherence, and effectiveness across populations, including underserved communities. With new funding, Arine plans to expand specialty pharmacy management, accelerate AI innovation to automate high-volume, low-complexity tasks, and integrate additional data to further personalize medication therapy. Arine is a medication intelligence startup that uses its platform to help health plans reduce medication errors, avoid complications, and keep patients out of the hospital. The company serves health plans and risk-bearing providers by improving medication safety and lowering cost of care. Founded in 2017 and based in San Francisco, Arine provides technology to enable better clinical and financial outcomes around medications. Arine plans to use the new funding to advance its platform capabilities to enable value-based care at scale. It intends to expand offerings beyond health plans and providers to other channel partners across the value-based care continuum. The company raised the financing as a mix of equity and debt to support that product and market expansion. Arine is an AI-driven platform that optimizes medication management for health plans and providers. The platform intakes clinical, social, and behavioral data and uses thousands of algorithms to recommend just-in-time clinical interventions for each patient. Those timely interventions are intended to reduce the total cost of care and drive a significant ROI, and the company states it saves one in every six healthcare dollars spent. Arine currently actively manages 5.5M lives. The company plans to use new funding to rapidly scale its team and its technology platform. Its product enables clinicians to provide personalized care by creating a whole picture of each patient based on multi-source data.